(Q43860642)
Statements
Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer (English)
Janine G Einspahr
David S Alberts
Mark A Nelson
Kathylynn Saboda
James Warneke
G Timothy Bowden